Nature's Sunshine Products (NATR) AI Stock Analysis

• Market Cap: $262.42M
• Dividend Yield: N/A
• Average Volume (3M): 51.41K
• Price to Earnings (P/E): 26.6
• Beta (1Y): 0.66
• Revenue Growth: 2.00%
• EPS Growth: -37.09%
• Country: US
• Employees: 819
• Sector: Consumer Defensive
• Sector Strength: 63
• Industry: Packaged Foods
• EPS (TTM): 0.25
• Shares Outstanding: 18,350,801
• 10 Day Avg. Volume: 60,834
• 30 Day Avg. Volume: 51,405
• PEG Ratio: -2.98
• Price to Book (P/B): 1.13
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -23.24
• Enterprise Value/Market Cap: 0.46
• Enterprise Value/Revenue: 0.07
• Enterprise Value/Gross Profit: 0.37
• Enterprise Value/Ebitda: 0.89
• 1Y Price Target: $20.00
• Price Target Upside: 38.41% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 2

• Rating: 77 Outperform
• Price Target: $17.00 ▲(17.65%Upside)

Nature's Sunshine Products displays strong financial health, robust cash flow, and a stable balance sheet, contributing to a solid foundation in the packaged foods industry. The stock exhibits positive technical momentum, although it's nearing overbought levels. Valuation is less attractive due to a high P/E ratio and no dividend yield, but recent earnings results and strategic expansion efforts in key markets provide reasons for optimism. Challenges in North America and macroeconomic uncertainties are noted, but overall, the stock is well-positioned for future growth.

Positive Factors

Financial Performance

Nature's Sunshine has grown sales by approximately 25% since 2018, despite a major transition away from the direct selling model in the US.

Market Expansion

Revenue growth led by Asia Pacific and Europe, marked by ongoing momentum and market expansion.

Profitability

The company has become significantly more profitable, with management expecting adjusted EBITDA of $38-44M in FY25 compared to approximately $18M in 2017.

Negative Factors

North American Market Challenges

In North America, sales were down slightly due to weaker-than-anticipated customer activations.

Regional Sales Decline

North American sales were down -1.6% YOY and LATAM was down -4.8% YOY.

Tariff Risks

Tariffs could potentially have a $2-3M headwind to gross margin in FY25.

Nature's Sunshine Products Business Overview & Revenue Model

Company Description

Nature's Sunshine Products, Inc., a natural health and wellness company, primarily manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision. The company also provides immunity, cardiovascular, and digestive products; and personal care products, such as oils and lotions, aloe vera gels, herbal shampoos, herbal skin treatment, toothpaste, and skin cleansers, as well as weight management products. It offers its products under the Nature's Sunshine and Synergy WorldWide brands through a sales force of independent consultants. The company was founded in 1972 and is headquartered in Lehi, Utah.

How the Company Makes Money

Nature's Sunshine Products generates revenue primarily through the direct selling of its health and wellness products. The company employs a multi-level marketing (MLM) strategy, where independent distributors sell products directly to consumers and can also recruit new distributors, earning commissions and bonuses based on their sales and the sales of their recruits. This business model enables the company to expand its market reach without the overhead costs associated with traditional retail channels. Additionally, Nature's Sunshine benefits from its strong global presence, with operations in numerous international markets, further diversifying its revenue streams. Partnerships with research institutions and investments in product innovation also play a critical role in sustaining the company's competitive edge and profitability.

Nature's Sunshine Products Financial Statement Overview

Summary

Nature's Sunshine Products exhibits solid financial health characterized by steady revenue growth, strong cash flow generation, and a stable balance sheet. While profitability metrics show room for enhancement, the company's low debt levels and efficient cash management provide a strong foundation for future growth. The consistent performance across financial statements demonstrates resilient operations in the packaged foods industry.

Income Statement

Nature's Sunshine Products shows strong financial performance with consistent revenue growth and profitability. The TTM revenue growth rate of 0.50% indicates a steady increase in sales compared to the previous year. The gross profit margin remains robust at 71.67%, while the net profit margin improved slightly to 2.22%. Both EBIT and EBITDA margins are healthy at 4.74% and 7.46%, respectively, demonstrating efficient operations. However, the net profit margin is relatively low, suggesting room for improvement in cost management.

Balance Sheet

The company's balance sheet is stable with a low debt-to-equity ratio of 0.09, indicating minimal reliance on debt financing. Return on equity (ROE) is modest at 6.28%, reflecting moderate profitability relative to shareholder equity. The equity ratio is strong at 63.84%, signifying solid financial positioning and low leverage. Although the balance sheet is healthy, the growth in equity is gradual, indicating potential for further strengthening.

Cash Flow

Cash flow metrics for Nature's Sunshine Products are strong, with a significant free cash flow growth rate of 20.92%. The operating cash flow to net income ratio is 2.54, highlighting efficient cash generation relative to earnings. Additionally, the free cash flow to net income ratio of 1.71 indicates robust cash flow management, allowing for potential reinvestment or dividend distributions. The cash position is well-managed, contributing to financial flexibility.

Breakdown
TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement		Total Revenue
456.62M	454.36M	445.32M	421.91M	444.08M	385.20M
	Gross Profit
327.31M	324.69M	321.13M	299.76M	328.62M	283.93M
	EBIT
21.64M	20.09M	18.75M	16.26M	34.67M	21.48M
	EBITDA
34.06M	32.79M	32.09M	31.15M	45.83M	32.23M
	Net Income Common Stockholders
10.12M	7.70M	15.08M	-390.00K	28.85M	21.34M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
86.49M	84.70M	82.37M	60.03M	86.18M	92.07M
	Total Assets
252.70M	240.85M	249.77M	229.78M	258.87M	249.50M
	Total Debt
14.85M	14.20M	14.92M	19.18M	22.99M	26.33M
	Net Debt
-71.64M	-70.50M	-67.45M	-40.85M	-63.20M	-65.74M
	Total Liabilities
85.60M	79.86M	90.23M	82.73M	97.47M	92.26M
	Stockholders Equity
161.28M	155.31M	154.06M	142.91M	158.20M	155.39M
Cash Flow		Free Cash Flow
17.32M	14.33M	30.75M	-6.92M	27.94M	32.75M
	Operating Cash Flow
25.72M	25.30M	41.23M	710.00K	34.61M	37.66M
	Investing Cash Flow
-8.39M	-10.97M	-10.48M	-7.63M	-6.61M	-4.91M
	Financing Cash Flow
-10.74M	-9.90M	-7.96M	-16.25M	-31.72M	3.88M

Nature's Sunshine Products Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 14.45
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For NATR, the sentiment is Neutral. The current price of 14.45 is below the 20-day moving average (MA) of 14.61, above the 50-day MA of 13.23, and above the 200-day MA of 13.97, indicating a neutral trend. The MACD of 0.28 indicates Positive momentum. The RSI at 50.71 is Neutral, neither overbought nor oversold. The STOCH value of 46.92 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for NATR.

Nature's Sunshine Products Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
NATR	77 Outperform	$262.42M	26.57	6.42%	―	2.00%	-37.09%
FTLF	75 Outperform	$131.48M	15.29	25.89%	―	9.14%	18.87%
MAMA	72 Outperform	$306.15M	73.74	18.79%	―	17.04%	-23.81%
LFVN	70 Outperform	$158.36M	18.02	30.11%	1.43%	8.22%	159.71%
Sector *	65 Neutral	$8.92B	15.03	4.68%	6.11%	3.59%	-2.49%
LSF	53 Neutral	$71.66M	―	-7.38%	―	25.04%	87.51%
HAIN	44 Neutral	$168.77M	―	-31.83%	―	-8.50%	-186.18%

Nature's Sunshine Products Corporate Events

Nature’s Sunshine CEO Terrence Moorehead Steps Down

On May 28, 2025, Terrence O. Moorehead, the President and CEO of Nature’s Sunshine Products, Inc., announced his decision to step down from his roles, pending the appointment of a successor. This leadership change, announced on June 2, 2025, could impact the company’s strategic direction and stakeholder confidence as it navigates the transition.

The most recent analyst rating on (NATR) stock is a Buy with a $18.00 price target. To see the full list of analyst forecasts on Nature’s Sunshine Products stock, see the NATR Stock Forecast page.

Nature’s Sunshine Products 2025 Shareholders Meeting Outcomes

Nature’s Sunshine Products held its 2025 Annual Meeting of Shareholders on April 30, 2025, where shareholders voted on several key proposals. The shareholders elected all nominated directors, approved an advisory resolution on executive officer compensation, and ratified the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for 2025.